Annual D&A
$408.00 K
-$27.20 K-6.25%
December 31, 2023
Summary
- As of February 8, 2025, ENVB annual depreciation & amortization is $408.00 thousand, with the most recent change of -$27.20 thousand (-6.25%) on December 31, 2023.
- During the last 3 years, ENVB annual D&A has risen by +$287.10 thousand (+237.47%).
- ENVB annual D&A is now -87.32% below its all-time high of $3.22 million, reached on December 31, 2017.
Performance
ENVB Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$84.80 K
$0.000.00%
September 30, 2024
Summary
- As of February 8, 2025, ENVB quarterly depreciation & amortization is $84.80 thousand, unchanged on September 30, 2024.
- Over the past year, ENVB quarterly D&A has stayed the same.
- ENVB quarterly D&A is now -92.57% below its all-time high of $1.14 million, reached on December 31, 2019.
Performance
ENVB Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$339.50 K
-$11.00 K-3.14%
September 30, 2024
Summary
- As of February 8, 2025, ENVB TTM depreciation & amortization is $339.50 thousand, with the most recent change of -$11.00 thousand (-3.14%) on September 30, 2024.
- Over the past year, ENVB TTM D&A has dropped by -$11.00 thousand (-3.14%).
- ENVB TTM D&A is now -89.86% below its all-time high of $3.35 million, reached on March 31, 2018.
Performance
ENVB TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
ENVB Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -6.3% | 0.0% | -3.1% |
| 3 y3 years | +237.5% | -6.2% | -22.0% |
| 5 y5 years | -86.0% | +100.0% | -70.3% |
ENVB Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -40.1% | at low | -57.0% | +0.4% | -50.2% | at low |
| 5 y | 5-year | -82.0% | +237.5% | -92.6% | +115.2% | -85.0% | +212.4% |
| alltime | all time | -87.3% | +508.0% | -92.6% | +115.2% | -89.9% | +212.4% |
Enveric Biosciences Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $84.80 K(0.0%) | $339.50 K(-3.1%) |
| Jun 2024 | - | $84.80 K(-0.7%) | $350.50 K(-7.8%) |
| Mar 2024 | - | $85.40 K(+1.1%) | $380.10 K(-6.8%) |
| Dec 2023 | $408.00 K(-6.3%) | $84.50 K(-11.8%) | $408.00 K(-1.4%) |
| Sep 2023 | - | $95.80 K(-16.3%) | $413.90 K(-5.8%) |
| Jun 2023 | - | $114.40 K(+1.0%) | $439.20 K(-1.3%) |
| Mar 2023 | - | $113.30 K(+25.3%) | $444.80 K(+2.2%) |
| Dec 2022 | $435.20 K(-36.2%) | $90.40 K(-25.4%) | $435.20 K(-19.7%) |
| Sep 2022 | - | $121.10 K(+0.9%) | $542.10 K(-8.8%) |
| Jun 2022 | - | $120.00 K(+15.7%) | $594.70 K(-8.3%) |
| Mar 2022 | - | $103.70 K(-47.4%) | $648.70 K(-4.8%) |
| Dec 2021 | $681.60 K(+463.8%) | $197.30 K(+13.6%) | $681.60 K(+12.6%) |
| Sep 2021 | - | $173.70 K(-0.2%) | $605.20 K(+40.3%) |
| Jun 2021 | - | $174.00 K(+27.4%) | $431.50 K(-242.8%) |
| Mar 2021 | - | $136.60 K(+13.0%) | -$302.10 K(-349.9%) |
| Dec 2020 | $120.90 K(-94.7%) | $120.90 K(>+9900.0%) | $120.90 K(-89.4%) |
| Sep 2020 | - | $0.00(-100.0%) | $1.14 M(0.0%) |
| Jun 2020 | - | -$559.60 K(-200.0%) | $1.14 M(-49.6%) |
| Mar 2020 | - | $559.60 K(-51.0%) | $2.26 M(-0.1%) |
| Dec 2019 | $2.27 M(-22.0%) | $1.14 M(>+9900.0%) | $2.27 M(+28.7%) |
| Sep 2019 | - | $0.00(-100.0%) | $1.76 M(-26.6%) |
| Jun 2019 | - | $562.60 K(+0.3%) | $2.40 M(-9.3%) |
| Mar 2019 | - | $561.00 K(-11.9%) | $2.64 M(-8.9%) |
| Dec 2018 | $2.90 M(-9.7%) | $637.10 K(+0.1%) | $2.90 M(-7.9%) |
| Sep 2018 | - | $636.50 K(-21.4%) | $3.15 M(-5.4%) |
| Jun 2018 | - | $809.30 K(-1.4%) | $3.33 M(-0.5%) |
| Mar 2018 | - | $820.70 K(-7.3%) | $3.35 M(+4.1%) |
| Dec 2017 | $3.22 M(+136.4%) | $885.10 K(+8.3%) | $3.22 M(+8.3%) |
| Sep 2017 | - | $817.30 K(-1.0%) | $2.97 M(+11.6%) |
| Jun 2017 | - | $825.70 K(+19.8%) | $2.66 M(+37.4%) |
| Mar 2017 | - | $689.10 K(+7.9%) | $1.94 M(+42.4%) |
| Dec 2016 | $1.36 M(+718.5%) | $638.80 K(+25.4%) | $1.36 M(+88.4%) |
| Sep 2016 | - | $509.40 K(+402.4%) | $722.40 K(+224.8%) |
| Jun 2016 | - | $101.40 K(-9.1%) | $222.40 K(+61.9%) |
| Mar 2016 | - | $111.60 K(+1087.2%) | $137.40 K(+432.6%) |
| Dec 2015 | $166.30 K(+347.0%) | - | - |
| Sep 2015 | - | $9400.00(-42.7%) | $25.80 K(+57.3%) |
| Jun 2015 | - | $16.40 K(-240.2%) | $16.40 K(+100.0%) |
| Sep 2007 | - | -$11.70 K(-301.7%) | $8200.00(-72.2%) |
| Jun 2007 | - | $5800.00(0.0%) | $29.50 K(-11.4%) |
| Mar 2007 | - | $5800.00(-30.1%) | $33.30 K(-10.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2006 | $37.20 K(-21.5%) | $8300.00(-13.5%) | $37.10 K(-3.4%) |
| Sep 2006 | - | $9600.00(0.0%) | $38.40 K(+1.1%) |
| Jun 2006 | - | $9600.00(0.0%) | $38.00 K(-4.3%) |
| Mar 2006 | - | $9600.00(0.0%) | $39.70 K(-16.2%) |
| Dec 2005 | $47.40 K(-19.5%) | $9600.00(+4.3%) | $47.40 K(+8.2%) |
| Sep 2005 | - | $9200.00(-18.6%) | $43.80 K(-16.9%) |
| Jun 2005 | - | $11.30 K(-34.7%) | $52.70 K(-10.7%) |
| Mar 2005 | - | $17.30 K(+188.3%) | $59.00 K(+0.3%) |
| Dec 2004 | $58.90 K(-29.0%) | $6000.00(-66.9%) | $58.80 K(-15.6%) |
| Sep 2004 | - | $18.10 K(+2.8%) | $69.70 K(-1.1%) |
| Jun 2004 | - | $17.60 K(+2.9%) | $70.50 K(-5.0%) |
| Mar 2004 | - | $17.10 K(+1.2%) | $74.20 K(-10.5%) |
| Dec 2003 | $82.90 K(-21.4%) | $16.90 K(-10.6%) | $82.90 K(-19.6%) |
| Sep 2003 | - | $18.90 K(-11.3%) | $103.10 K(-0.7%) |
| Jun 2003 | - | $21.30 K(-17.4%) | $103.80 K(+2.0%) |
| Mar 2003 | - | $25.80 K(-30.5%) | $101.80 K(-3.5%) |
| Dec 2002 | $105.50 K(-24.2%) | $37.10 K(+89.3%) | $105.50 K(-25.3%) |
| Sep 2002 | - | $19.60 K(+1.6%) | $141.20 K(-1.6%) |
| Jun 2002 | - | $19.30 K(-34.6%) | $143.50 K(-2.2%) |
| Mar 2002 | - | $29.50 K(-59.5%) | $146.80 K(+5.5%) |
| Dec 2001 | $139.10 K(+61.7%) | $72.80 K(+232.4%) | $139.20 K(+57.6%) |
| Sep 2001 | - | $21.90 K(-3.1%) | $88.30 K(0.0%) |
| Jun 2001 | - | $22.60 K(+3.2%) | $88.30 K(+1.5%) |
| Mar 2001 | - | $21.90 K(0.0%) | $87.00 K(+1.2%) |
| Dec 2000 | $86.00 K(-17.0%) | $21.90 K(0.0%) | $86.00 K(+34.2%) |
| Sep 2000 | - | $21.90 K(+2.8%) | $64.10 K(+51.9%) |
| Jun 2000 | - | $21.30 K(+1.9%) | $42.20 K(+101.9%) |
| Mar 2000 | - | $20.90 K(-90.8%) | $20.90 K(-83.5%) |
| Dec 1999 | $103.60 K(-18.0%) | - | - |
| Dec 1998 | $126.30 K(-69.0%) | $226.30 K(>+9900.0%) | $126.30 K(-75.1%) |
| Sep 1998 | - | $0.00(0.0%) | $507.20 K(+24.6%) |
| Jun 1998 | - | $0.00(-100.0%) | $407.20 K(0.0%) |
| Mar 1998 | - | -$100.00 K(-116.5%) | $407.20 K(0.0%) |
| Dec 1997 | $407.20 K(+213.0%) | $607.20 K(-707.2%) | $407.20 K(+1252.8%) |
| Sep 1997 | - | -$100.00 K(<-9900.0%) | $30.10 K(0.0%) |
| Jun 1997 | - | $0.00(-100.0%) | $30.10 K(0.0%) |
| Mar 1997 | - | -$100.00 K(-143.5%) | $30.10 K(-76.9%) |
| Dec 1996 | $130.10 K(-230.1%) | $230.10 K(-330.1%) | $130.10 K(-230.1%) |
| Sep 1996 | - | -$100.00 K | -$100.00 K |
| Dec 1995 | -$100.00 K(0.0%) | - | - |
| Aug 1994 | -$100.00 K | - | - |
FAQ
- What is Enveric Biosciences annual depreciation & amortization?
- What is the all time high annual D&A for Enveric Biosciences?
- What is Enveric Biosciences annual D&A year-on-year change?
- What is Enveric Biosciences quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Enveric Biosciences?
- What is Enveric Biosciences quarterly D&A year-on-year change?
- What is Enveric Biosciences TTM depreciation & amortization?
- What is the all time high TTM D&A for Enveric Biosciences?
- What is Enveric Biosciences TTM D&A year-on-year change?
What is Enveric Biosciences annual depreciation & amortization?
The current annual D&A of ENVB is $408.00 K
What is the all time high annual D&A for Enveric Biosciences?
Enveric Biosciences all-time high annual depreciation & amortization is $3.22 M
What is Enveric Biosciences annual D&A year-on-year change?
Over the past year, ENVB annual depreciation & amortization has changed by -$27.20 K (-6.25%)
What is Enveric Biosciences quarterly depreciation & amortization?
The current quarterly D&A of ENVB is $84.80 K
What is the all time high quarterly D&A for Enveric Biosciences?
Enveric Biosciences all-time high quarterly depreciation & amortization is $1.14 M
What is Enveric Biosciences quarterly D&A year-on-year change?
Over the past year, ENVB quarterly depreciation & amortization has changed by $0.00 (0.00%)
What is Enveric Biosciences TTM depreciation & amortization?
The current TTM D&A of ENVB is $339.50 K
What is the all time high TTM D&A for Enveric Biosciences?
Enveric Biosciences all-time high TTM depreciation & amortization is $3.35 M
What is Enveric Biosciences TTM D&A year-on-year change?
Over the past year, ENVB TTM depreciation & amortization has changed by -$11.00 K (-3.14%)